SP Ventures Exits Brazilian Biotech Firm Bug with Sale to Koppert (em português)

18 December 2017

SP Ventures Bug Agentes Biológicos LAVCA

SP Ventures exited Bug Agentes Biológicos, a Brazilian biotech firm, though a sale to Dutch biochemical company Koppert Biological Systems.

(Valor Econômico) A holandesa Koppert fechou a aquisição, por meio de sua subsidiária brasileira, da Bug Agentes Biológicos, com sede em Piracicaba. Com a aquisição da empresa de controle biológico, cujo valor não foi divulgado, a Koppert afirma chegar ao primeiro lugar no ranking do setor na América Latina.

Tweets

Missing consumer key - please check your settings in admin > Settings > Twitter Feed Auth

Keep in touch

Twitter Linkedin Youtube

About LAVCA

LAVCA is the Association for Private Capital Investment in Latin America, a not-for-profit membership organization dedicated to supporting the growth of private capital in Latin America and the Caribbean through research, education, networking and advocacy.

LAVCA Office

    New York City:
    589 8th Ave, 18th Floor
    New York, NY 10018

Explore LAVCA.org

About LAVCA
Board, Team, & Advisors
Media
Contact Us
Membership Benefits
Members Only Access
Education and Programs
Research
Policy
LAVCA VC

Contact Us

Back To Top